LATEST ALERTS
Figures published as part of New York state’s lawsuit against flavoured e-cigarette companies show just how big the market has been for vaping firms
British American Tobacco (BAT) reported a decline in revenues for the year, offset by a positive performance in new categories across all three regions
Philip Morris International (PMI) achieved positive results last year, with its vaping brand Veev playing a significant role in the company’s smoke-free multi-category strategy
Altria released its fourth-quarter and full-year financial results today, revealing progress and ongoing challenges in its business strategy – particularly concerning the acquisition of its e-cigarette brand, Njoy
Agile companies will benefit from regulatory adversity, according to Supreme. The multi-product retailer expects the proposed UK vaping tax to lead to consolidation in the market
Imperial Brands unveiled its 2024 full-year financial results, calling attention to significant strides in the next-generation product (NGP) category, with vaping leading the charge
US-based vaping company Ispire Technology has reported its fiscal first-quarter 2025 results, underscoring significant developments in its vaping and nicotine product offerings
Altria’s third-quarter results underscored significant growth in its reduced-risk portfolio, with the Njoy brand leading the way and broadening its retail footprint
November will mark ten years since Iqos was launched in Japan. And as the third-quarter results of Philip Morris International show, the last ten years have been quite the story in the product’s global brand-building
Philip Morris International (PMI) highlighted the performance of its smoke-free products during its third-quarter results presentation, with the category growing to reach 38% of the company’s total net revenue
Imperial Brands reported trading in line with expectations, driven by robust growth in its tobacco segment and next generation products, as it prepares to give its full-year results in November
All Big Tobacco companies reported growth in their smoke-free segments, reflecting a trend towards diversification from traditional cigarettes, though none have addressed the regulatory environment and its potential impact on future earnings
Altria reported encouraging results for its e-cigarette brand Njoy, as well as rapid expansion of in-store distribution in the second quarter of 2024. It said it strengthened Njoy’s supply chain and tripled its footprint
British American Tobacco reported a drop in first-half revenue, offset by the continued growth of new categories. BAT expects new-category revenue to be weighted in the second half of 2024, driven by phased launches
Philip Morris International recorded a multi-category, smoke-free expansion in the first half of the year. Its Veev vaping products have become the closed-pod leader in five European markets within 12 months of launch
Supreme nearly doubled its adjusted operating profits in the financial year ended on 31st March – partly driven by the growth of its vaping division and its distribution of disposable e-cig brands
Imperial Brands delivered a solid performance for the first half of the year ended 31st March 2024, boosted by scaling up its existing footprint and stepping up innovation across all next-generation product categories
Altria reported its first-quarter earnings with encouraging results from e-cigarette manufacturer Njoy, which it says is showing early momentum since its aquisition last year
British American Tobacco (BAT) saw its new category products achieve profitability two years ahead of schedule driven by the global performance of its Vuse e-cigarette brand
UK consumer goods company Supreme expects to outperform its market forecasts for the 2024 financial year, despite a third of its revenue coming from the distribution of disposables
During the presentation of its financial results for the year and the fourth quarter, Altria said it will look to support expansion plans behind its $2.75bn acquisition of the Njoy e-cigarette brand in the new year
Haypp Group, an online retailer of reduced-risk products, will look to expand into new categories and European markets following the success of a vaping pilot in the UK
UK consumer goods company Supreme scored record-high revenues in the six months ending 30th September, partly due to growth in the vaping area of its business, the company said
Imperial Brands reported a performance in line with its five-year-plan expectations in the year ended 30th September 2023, with new product and market launches boosting its next-generation product (NGP) revenue
Altria will look to strengthen the logistics behind its recent $2.75bn acquisition of the Njoy e-cigarette brand as it sets out to build on revenues from alternatives to conventional cigarettes
UK vape maker Supreme has outlined measures to mitigate increased interest from under-age consumers in its 88Vape brand and reduce the environmental impact of disposables
Altria reported a solid performance in the first half of 2023, supported by the $2.75bn acquisition of e-cigarette manufacturer Njoy, which was finalised in June
British American Tobacco’s vapour brand Vuse was the key driver of the company’s positive performance in the first half of the year, and it remains confident in its Vuse Alto pre-market tobacco product application submission to the US Food and Drug Administration
Tobacco giant Altria confirmed it had completed its acquisition of e-cigarette maker Njoy for $2.75bn, having cleared antitrust checks in the US
US tobacco giant Altria closed the first quarter of 2023 with a slight fall in its net revenues compared with the same period last year, after divesting from Juul Labs and agreeing to purchase Njoy
Philip Morris International will scale back and partially outsource its vaping business, instead focusing on other tobacco alternatives that can help it become a majority smoke-free revenue company by 2025
Expanding sales of Imperial Brands’ next generation products into new markets has more than compensated the company for the effect of the US Food and Drug Administration (FDA)’s marketing denial order (MDO) for Myblu
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Get 7 days of FREE platform access: Demo our data contents without commitment
"*" indicates required fields
Notifications
